Article
Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Jul 2008
Takada Yasutsugu, Ito Takashi, Ueda Yoshihide, Haga Hironori, Egawa Hiroto, Tanaka Koichi, Uemoto Shinji
Abstract excerpt
Response rates to interferon and ribavirin treatment for recipients with recurrent hepatitis C virus (HCV) infection are suboptimal, particularly for those with genotype 1b and high viral load. The present study evaluated the effects of combining double-filtration plasmapheresis (DFPP) with pharmacotherapy using interferon plus ribavirin after living donor liver transplantation. DFPP was applied in the first week...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.